Anthem Biosciences IPO GMP: The IPO attracted strong interest, receiving bids for 17.66 crore shares against 4.4 crore shares on offer. Non-institutional investors (NIIs) led the demand, subscribing 12.37 times their allotted quota. The retail segment saw 2.38 times subscription, while qualified institutional buyers (QIBs) subscribed to 60% of their portion.
Geopolitics, crude risk and the IT conundrum: Sridhar Sivaram on why investors may need to stay selective
Geopolitical tensions in West Asia are creating market uncertainty, impacting energy supplies and capital flows. While Indian equities have shown resilience, prolonged conflict could significantly